BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:10 PM
 | 
Apr 29, 2010
 |  BC Extra  |  Company News

sanofi-aventis updates pipeline, reports earnings

sanofi-aventis Group (Euronext:SAN; NYSE:SNY) reported in its 1Q10 earnings that FDA accepted for filing and granted Priority Review to a rolling NDA for Jevtana cabazitaxel to treat second-line prostate cancer. The PDUFA...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >